Departed
John Proust
Director
RYES ·
Rise Gold Corp.
On October 30, 2024, John Proust, Murray Flanigan and Benjamin Mossman resigned as directors of Rise Gold Corp.
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 5951–6000 of 75392
On October 30, 2024, John Proust, Murray Flanigan and Benjamin Mossman resigned as directors of Rise Gold Corp.
On October 25, 2024, Robert Switz, Chair of the Board of Directors (the “Board”) of Micron Technology, Inc. (the “Company”), provided notice to the Governance and Sustainability Committee of the Board that he has decided to retire from the Board and will not seek re-election at the Company’s fiscal 2024 annual shareholders meeting (the “Annual Meeting”).
On October 24, 2024, Michael Torok notified Carisma Therapeutics Inc. (the “Company”) of his decision to resign from the Company’s board of directors (the “Board”), effective October 31, 2024.
Mr. Morgenthau was appointed to fill the vacancy on the Board of Directors of the Company and the Bank resulting from the death of Kevin P. O’Malley, who had served as a director since 2016.
On October 29, 2024, Robert J. Sheedy, Jr. agreed to step down as the Company’s President and Chief Executive Officer and resign as a member of the Board, effective immediately.
On October 24, 2024, Lance Mitchell notified the Company that he plans to step down as President and Chief Executive Officer of the Company and as a member of the Company's Board, all effective as of January 1, 2025.
On October 24, 2024, Lance Mitchell notified the Company that he plans to step down as President and Chief Executive Officer of the Company and as a member of the Company's Board, all effective as of January 1, 2025.
On October 25, 2024, Dr. Scott Koenig, the President and Chief Executive Officer of MacroGenics, Inc. (the “ Company ”) and the Company entered into a separation and consulting agreement, dated October 25, 2024 (the “ Separation Agreement ”), which provides for the terms of Dr. Koenig’s separation from employment, effective February 28, 2025
As of the Separation Date, Mr. Hartman’s service relationship with the Company will cease.
Joseph W. Gorder has elected to retire from his position as Executive Chairman and as a member of the of the board of directors of Valero (the “Board”) effective as of the close of business on December 31, 2024 (the “Effective Date”).
On October 25, 2024, Deneen Vojta, MD notified the Chair of the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) of her decision to resign from the Board, effective December 31, 2024.
On October 28, 2024, Michael McDonnell, Chief Financial Officer of Biogen Inc. (the “Company”) notified the Company that he will retire from the Company effective February 28, 2025.
On October 30, 2024, Valley National Bancorp (the “Company”) announced that Michael Hagedorn will separate from service as Senior Executive Vice President and Chief Financial Officer of the Company effective as of November 30, 2024.
Michael J Arougheti will cease to serve as Chairperson of the Board and will continue to serve as a Class I director of the Board.
Concurrently with James R. Miller’s appointment, Mitchell Goldstein stepped down as Co-President
Mr. McRoberts is stepping down from his role as COO effective October 31, 2024
On October 29, 2024, Randall S. Wade, a member of the board of directors of the general partner of NGL Energy Partners LP (the “Partnership”), notified the Partnership that he will be resigning from his board position effective October 30, 2024.
the Board of Directors accepted the resignations of Mr. Wolfgang Ruecker and Mr. William “Billy” Bollander from all positions
the Board of Directors accepted the resignations of Mr. Wolfgang Ruecker and Mr. William “Billy” Bollander from all positions
Mr. Colvin submitted his resignation from the positions to which he had been appointed.
On October 27, 2024, Shashank Patel, the Registrant’s Chief Financial Officer, provided notice of his intention to retire from the Registrant effective as of March 15, 2025.
On October 28, 2024, the Company announced the retirement of Joseph F. Woody as Chief Executive Officer and a member of the Board of Directors of the Company, effective immediately.
as of November 15, 2024, at which time Tom Fitzgerald will no longer serve as the Company’s principal financial officer.
On October 3, 2024, the Board accepted the resignation of Dean Kolocouris, effective immediately.
On October 26, 2024, Mr. Martin Tian informed the Board of Directors (the “Board”) of Landsea Homes Corporation (the “Company”) of his intention to step down from his role as a member of the Board, effective the same day.
On October 25, 2024, Amy Cappellanti-Wolf and Emil Michael provided D-Wave Quantum Inc. (the “Company”) with final notice of resignation as directors of the Board of Directors of the Company (the “Board”), effective as of October 28, 2024.
On October 25, 2024, Amy Cappellanti-Wolf and Emil Michael provided D-Wave Quantum Inc. (the “Company”) with final notice of resignation as directors of the Board of Directors of the Company (the “Board”), effective as of October 28, 2024.
Effective October 25, 2024, Jack Stein, who was one of GPC Partners Investments (SPV III) LP’s (“GPC Fund”) nominees to the board of directors (the “Board”) of Bowhead Specialty Holdings Inc. (the “Company”) pursuant to GPC Fund’s rights under the Board Nominee Agreement, dated as of May 23, 2024, between the Company and GPC Fund, resigned from the Board.
Mr. Pogalz succeeds Scott Robinson, who, on October 25, 2024, gave notice of his retirement from the Company, resigning from the office of Chief Financial Officer effective at the close of business on October 31, 2024, and retiring from his employment effective at the close of business on December 6, 2024.
On October 23, 2024, Blanche L. Lincoln notified Entergy Corporation (the “Company”) that she intends to resign from the Board of Directors of the Company effective December 31, 2024.
Following a review by outside counsel, on October 24, 2024, the Board of Directors (the “Board”) of Masimo adopted resolutions to terminate the employment of Masimo’s Chief Executive Officer, Joe Kiani, effective October 24, 2024.
Michael J. Burbach, age 63, notified on July 30, 2024, the Company of his intent to retire from his position as our Chief Operating Officer, effective December 31, 2024.
On Sunday, October 26, 2024, Jonathon Walton, our director, resigned. There were no disagreements of any kind with Mr. Walton.
On October 23, 2024, Robert Yau, a member of the Board of Directors of GSI Technology, Inc. (the “Corporation”), notified the Board of Directors of his retirement from the Board of Directors, effective immediately.
On October 24, 2024, Laurence B. Mindel, a member of the Board of Directors of the Company (the “Board”), notified the Board of his intention to retire from the Board, effective immediately.
On October 24, 2024, Jarrod Yahes notified Shutterstock, Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective November 1, 2024
On October 23, 2024, Jill Sutton resigned from the board of directors (the “Board”) of Pitney Bowes Inc. (the “Company”).
on October 23, 2024, Mr. Wolfe transitioned out of such position
Effective October 23, 2024, Peter Kampian voluntarily resigned as Chief Financial Officer of 4Front Ventures Corp. (the “Company”).
On October 25, 2024, the Company's President and Chief Executive Officer, Andres Reiner, notified the Company's Board of Directors (the "Board") that he intends to retire from his position, effective upon his successor’s appointment as the Company’s Chief Executive Officer.
Effective October 28, 2024, G.F. (Rick) Ringler, III, age 77, Director of Forestar Group Inc. ( the “Company” ), resigned from the Company’s Board of Directors ( the “Board” ), including his positions as a member of the Audit Committee and Compensation Committee and as Chair of the Nominating and Governance Committee.
Effective September 30, 2024, Jian-Meng Yang resigned as Secretary of the Corporation and Summer Li was appointed Secretary in his place.
On October 27, 2024, Whitney White, Christopher Sebes, and Martin Scott resigned as directors of the Company.
On October 27, 2024, Whitney White, Christopher Sebes, and Martin Scott resigned as directors of the Company.
On October 27, 2024, Whitney White, Christopher Sebes, and Martin Scott resigned as directors of the Company.
On October 25, 2024, Mr. Mark Andersen informed FibroBiologics, Inc. (the “Company”) of his decision to voluntarily resign from his position as the Company’s Chief Financial Officer
On October 23, 2024, Elizabeth Ng notified the Company’s Board of Directors that she would be taking a sabbatical for personal reasons.
Mr. Paulsen will replace G. Tracy Owens as the principal financial officer of the Company, effective November 18, 2024.
On October 24, 2024, Greg W. Albers and Paul Branagan, Directors on the Registrant’s Board of Directors, resigned their positions.
On October 24, 2024, Gary J. Grieco stepped down from his position as Chairman of the Board and Chief Executive Officer of the Registrant.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.